MARKET

TXMD

TXMD

Therapeuticsmd Inc
NASDAQ
2.020
+0.070
+3.59%
Pre Market: 1.960 -0.06 -2.97% 04:00 05/14 EDT
OPEN
1.980
PREV CLOSE
1.950
HIGH
2.060
LOW
1.950
VOLUME
1
TURNOVER
--
52 WEEK HIGH
2.950
52 WEEK LOW
0.9811
MARKET CAP
23.38M
P/E (TTM)
-41.0569
1D
5D
1M
3M
1Y
5Y
1D
TherapeuticsMD Says Company Continues To Evaluate Strategic Alternatives, Including Acquisition Or Merger
Benzinga · 1d ago
TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives
TipRanks · 1d ago
Therapeutics MD reports Q1 results
Seeking Alpha · 1d ago
TherapeuticsMD swings to Q1 net income as license revenue rises
Reuters · 1d ago
TherapeuticsMD swings to FY26 Q1 profit of $103,000; revenue rises 84.2% to $724,000
PUBT · 1d ago
THERAPEUTICSMD INC - COMPANY CONTINUES TO EVALUATE STRATEGIC ALTERNATIVES INCLUDING ACQUISITION OR MERGER
Reuters · 1d ago
TherapeuticsMD: Q1 Earnings Snapshot
Barchart · 1d ago
Weekly Report: what happened at TXMD last week (0504-0508)?
Weekly Report · 3d ago
More
About TXMD
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).

Webull offers TherapeuticsMD Inc stock information, including NASDAQ: TXMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TXMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TXMD stock methods without spending real money on the virtual paper trading platform.